A novel web-based 24-hour dietary recall tool in line with the Nova food processing classification: description and evaluation

Abstract

Objective: This paper describes the first web based self completed 24 hour recall designed to categorize food intake according to Nova groups, Nova24h, and its agreement with a reference tool in estimating the dietary relative contribution of the four Nova food groups (% of total energy intake). Design: Comparisons of estimates of dietary relative contributions of Nova groups obtained by Nova24h and one standard interviewer-led 24-hour recall. Setting: Nationwide adult cohort study in Brazil Participants: The subjects were 186 participants of the NutriNet Brasil Cohort Study (n=186). Results: No statistically significant differences were observed between the Nova24h and the reference tool mean contributions of unprocessed or minimally processed foods (52.3% vs. 52.6%), processed culinary ingredients (11.6% vs. 11.9%), processed foods (17.1% vs. 14.7%) and ultra-processed foods (19.0% vs. 20.9%). Intraclass correlation coefficients between individual estimates obtained for each Nova group showed moderate to good agreement (0.54 to 0.78). Substantial or almost perfect agreement between the tools was seen regarding the ability to rank participants according to quintiles of contribution of each Nova group (PABAK 0.69 to 0.81). Conclusions: Nova24h is a suitable tool for estimating the dietary relative energy contribution of Nova food groups in the NutriNet Brasil cohort. New studies are necessary to verify its adequacy in other populations.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Brazilian National Council for Scientific and Technological Development (CNPq) (grant number 404211/2020-9). CNPq had no role in the design, analysis or writing of this article.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving research study participants were approved by the Human Subjects Research Office at the University of Sao Paulo (USP no. 2.728.201). Written informed consent was obtained from all subjects/patients.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

留言 (0)

沒有登入
gif